Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial
Sign Up to like & getrecommendations! Published in 2022 at "RMD Open"
DOI: 10.1136/rmdopen-2022-002303
Abstract: Objectives To investigate patient characteristics predictive of response to secukinumab in patients with psoriatic arthritis (PsA) with axial manifestations. Methods In a post-hoc analysis from the MAXIMISE trial (NCT02721966) in patients with PsA and axial… read more here.
Keywords: response; secukinumab patients; response secukinumab; axial manifestations ... See more keywords